| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 72.79M | — |
| Operating expense | — | — |
| Net income | -49.36M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SNDX returned +21.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -6.5% |
| 1 year | +21.0% |
| 5 years | +12.3% |
| 10 years | +38.6% |
| All-time high | $28.70 (Jan 2023) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SNDX would be worth today ›No. Syndax Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Syndax Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol SNDX.
Syndax Pharmaceuticals, Inc. is part of the Healthcare sector.
Syndax Pharmaceuticals, Inc. has a market cap of 1.75B USD, based on the latest quote.
Syndax Pharmaceuticals, Inc. is expected to report earnings around Nov 2, 2026. That date is an estimate and has not been confirmed by the company.
